Health

Results: 7189-7200 of 8689

Music Licensing, Inc. (OTC: SONG) Secures Intellectual Property Rights for Listerine "Mouthwash" Antiseptic

Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer

Caldera Medical's Humanitarian Effort Reaches New Heights: 400,000 Women Treated Worldwide

An Invitation to Innovaderm’s 5th Breakfast Event, This Year’s Focus is on Alopecia Areata (AA)

PR Newswire associated0

AtomVie Global Radiopharma Collaborates with RLS & UPPI to Strengthen its Existing U.S. Radiotherapeutic Distribution Network

ReNAgade Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference

MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update

CBD is approved for treatment-resistant epilepsy in children, and recent trials suggest that it may be useful for treating other disorders, such as schizophrenia and anxiety. Photo credit: Julia Zolotova

Quolet announces completion of Phase 1 healthy volunteer study evaluating the safety and bioavailability of Cannabidiol in a novel formulation intended for treatment of various neurological and psychiatric diseases

PR Newswire associated0

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN

Desert Control releases its Q4 2023 Report and Year-to-date Company Update

ICON Reports Fourth Quarter and Full Year 2023 Results